SHCBP1 and multiple sclerosis: Given the expression of Shcbp1 in inflammatory lesions within the spinal cord as well as reduced disease severity in Shcbp1 deficient mice, Shcbp1 may represent a therapeutic target for autoimmune disease such as multiple sclerosis.